Analysis of steroid profiles by mass spectrometry: A new tool for exploring adrenal tumors?
| dc.rights.license | open | en_US |
| dc.contributor.author | CAMBOS, Sophie | |
| dc.contributor.author | CHANSON, Philippe | |
| hal.structure.identifier | Neurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB] | |
| dc.contributor.author | TABARIN, Antoine | |
| dc.date.accessioned | 2022-03-25T13:05:39Z | |
| dc.date.available | 2022-03-25T13:05:39Z | |
| dc.date.issued | 2021-02 | |
| dc.identifier.issn | 0003-4266 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/136539 | |
| dc.description.abstractEn | The assay of multiple steroids by mass spectrometry coupled with chromatography, combined with data analysis using an artificial intelligence approach, has become more widely accessible in recent years. Multiple applications for this technology exist for the study of adrenocortical tumors. Taking advantage of the capacity of malignant cortical tumor secretion of non-bioactive precursors, it provides an additional diagnostic approach that can point to the nature of a tumor. These encouraging perspectives have been based to date only on pilot retrospective studies. However, this has changed in 2020 with the publication of data from the EURINE-ACT study. This very large prospective European study provided more nuanced evidence for the benefit of combining the measurement of a panel of steroids with essential imaging tools. This study also facilitated our understanding and provided more precise characterisation of autonomous steroid secretion, particularly in the case of sublinical cortisol-secreting adrenocortical adenomas. This article will focus on our current knowledge on the potential utility of mass spectrometry for diagnosis of both the nature of an adrenal tumors and their secretion. | |
| dc.language.iso | EN | en_US |
| dc.subject.en | Adrenal steroids | |
| dc.subject.en | Adrenal tumors | |
| dc.subject.en | Adrenocortical carcinoma | |
| dc.subject.en | Autonomous cortisol secreting adenoma | |
| dc.subject.en | Machine learning | |
| dc.subject.en | Mass spectrometry | |
| dc.title.en | Analysis of steroid profiles by mass spectrometry: A new tool for exploring adrenal tumors? | |
| dc.title.alternative | Ann Endocrinol | en_US |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1016/j.ando.2020.12.001 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Neurosciences [q-bio.NC] | en_US |
| dc.identifier.pubmed | 33278379 | en_US |
| bordeaux.journal | Annales d'Endocrinologie | en_US |
| bordeaux.page | 36-42 | en_US |
| bordeaux.volume | 82 | en_US |
| bordeaux.hal.laboratories | Neurocentre Magendie - UMR-S 1215 | en_US |
| bordeaux.issue | 1 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INSERM | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| hal.identifier | hal-03619932 | |
| hal.version | 1 | |
| hal.date.transferred | 2022-03-25T13:05:40Z | |
| hal.export | true | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Annales%20d'Endocrinologie&rft.date=2021-02&rft.volume=82&rft.issue=1&rft.spage=36-42&rft.epage=36-42&rft.eissn=0003-4266&rft.issn=0003-4266&rft.au=CAMBOS,%20Sophie&CHANSON,%20Philippe&TABARIN,%20Antoine&rft.genre=article |
Fichier(s) constituant ce document
| Fichiers | Taille | Format | Vue |
|---|---|---|---|
|
Il n'y a pas de fichiers associés à ce document. |
|||